(Q34591052)

3 August 2017

title

Decision-making in early breast cancer: guidelines and decision tools (English)

1 reference

3 August 2017

Baum M

1

1 reference

3 August 2017

Ravdin PM

series ordinal

2

1 reference

3 August 2017

publication date

1 April 2002

1 reference

European Journal of Cancer

3 August 2017

published in

1 reference

3 August 2017

volume

38

1 reference

3 August 2017

issue

6

1 reference

3 August 2017

page(s)

745-749

1 reference

Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900033-3

7 January 2021

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900033-3

7 January 2021

Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900033-3

7 January 2021

Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900033-3

7 January 2021

Evaluation of effectiveness: Q-TWiST. The International Breast Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900033-3

7 January 2021

Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: meta-analysis of quality-adjusted survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900033-3

7 January 2021

Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900033-3

7 January 2021

A bedside decision instrument to elicit a patient's preference concerning adjuvant chemotherapy for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900033-3

7 January 2021

Mastectomy or lumpectomy? Helping women make informed choices

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900033-3

7 January 2021

Breast irradiation postlumpectomy: development and evaluation of a decision instrument

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900033-3

7 January 2021

Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900033-3

7 January 2021

Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900033-3

7 January 2021

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900033-3

7 January 2021

10.1016/S0959-8049(02)00033-3

Identifiers

DOI

1 reference

3 August 2017

1 reference